Facebook
Twitter
LinkedIn
ForwardBowel Disorders: Update on Irritable Bowel Syndrome and Inflammatory Bowel Disease
In this online course, Faten N. Aberra, M.D., and Eamonn M. Quigley, M.D. will discuss advances in the field of inflammatory bowel disease and irritable bowel syndrome. These topics will provide learners with relevant information regarding new developments in gastroenterology and new approaches to the management of gastrointestinal diseases.
Target Audience
Gastroenterologists, Radiologists, General Practitioners, Internal Medicine Physicians, Surgeons, Residents, Nurses, Nurse Practitioners, Dietitians, Clinical Pharmacists, Clinical Laboratory Personnel, Physician Assistants, and all other interested healthcare professionals.
Learning Objectives
- Explain medical and nonmedical targeted therapies currently available for inflammatory bowel disease (IBD) and select therapies appropriately.
- Recognize the updated parameters of irritable bowel syndrome (IBS) and identify factors that can contribute to the pathogenesis of symptoms.
- Develop a treatment strategy for the main IBS subtypes.
- Review important unanswered questions about IBS.
Eamonn M. Quigley, M.D., FRCP, FACP, MACG, FRCPI, MWGO
David M. Underwood Chair of Medicine in Digestive Disorders
Co-director, Lynda K. and David M. Underwood Center for Digestive Disorders
Chief, Gastroenterology and Hepatology
Professor of Medicine, Institute of Academic Medicine, Houston Methodist Hospital
Professor of Medicine, Weill Cornell Medical College
Adjunct Professor of Medicine, Texas A&M Health Sciences Center College of Medicine
Adjunct Professor, School of Medicine, University College Cork
Houston, Texas
Faten N. Aberra, M.D., MSCE
Associate Professor of Medicine
Division of Gastroenterology
Hospital of the University of Pennsylvania
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Kenneth Rosenthal, M.D.
Gastroenterologist
Co-Chair Boca Raton Regional Hospital CME Committee
Boca Raton Regional Hospital
Baptist Health South Florida
Eamonn M. Quigley, M.D., faculty for this educational activity, is a researcher for 4D Pharma, Biomerica and Vibrant; a consultant for 4D Pharma, Vibrant, PrecisionBiotics, Novozymes, Salix and Allergan; and an adviser for Atlantia Foods. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Faten N. Aberra, M.D., faculty for this educational activity, is a researcher for AbbVie, Pfizer, Janssen, Target PharmaSolutions and UCB. He has indicated that the presentation or discussion will include off-label or unapproved product usage.
Kenneth Rosenthal, M.D., conference director of this educational activity, indicated that he is a member of the speakers’ bureau for AbbVie Pharmaceuticals.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Available Credit
- 2.00 ABIM MOC II
- 2.00 AMA PRA Category 1 Credit™
- 2.00 General certificate of attendance
- 2.00 Florida Board of Dietitians
- 2.00 Florida Board of Laboratory Personnel
- 2.00 Nurse Practitioners
- 2.00 Florida Board of Nursing
Price
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
